FDA Announces Comment Request for Automated Blood Cell Separator Device Guidance Document

Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The FDA is seeking industry and FDA staff feedback on a proposed guidance document for automated blood cell separator devices.